US Patent 7510830 Cancer treatment by combination therapy

Patent 7510830 was granted and assigned to Cancer Research Technology Limited on March, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 17 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 17 Sep, 2023

Edits made to:

Infobox (+3 properties)

Infobox

Patent Inventor Names

Bruce Charles Baguley0

Lai-Ming Ching0

Martin Philpott0

Edits on 15 Sep, 2023

"Add patent abstract"

Golden AI

edited on 15 Sep, 2023

Edits made to:

Article (+506 characters)

Article

Patent abstract

Methods and compositions are provided for treating cancer, the methods including the step administering, either sequentially or simultaneously, (i) a compound of the xanthenone acetic acid group of compounds, and (ii) at least one compound selected from compounds which modulate TNF production and compounds which act on biochemical pathways leading to TNF synthesis. Compositions include a combination of (i) and (ii) above, together with acceptable pharmaceutical carriers and/or vehicles.

Edits on 21 Jul, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 21 Jul, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=075108300

Edits on 15 Jul, 2023

"Remove leading 0 from patent number"

Golden AI